>PROKKA_00001 hypothetical protein
MKDIANDSYPIVEATGTNSYIGSSARITSLNKGTRCTLFVGSNAIGNCSLNLNNYGAKNI
KDSFGNIVNNLKANIPYNLCYNGSDFILQGKGGGGNATADKLLSGSTATVDSGSITGTMP
NQETKTATLNCGGSYIIPAGYHNGSGKVTANSLASQTPGNATAAQILAGFSAWVNGNNIN
GNATLQSLGGKKFKLGEATTPDGSSPRSVTVTVGFRPSLILVWRKTDTIPELEHVRTDLI
EANTYYYYSPWSGKTSVIDNGFILSESYNSSGKGKNYVYMCIA*
>PROKKA_00002 hypothetical protein
MKILAVYNNKGQLIFLQTNATEQCSCLVEEVEDNKEVIGIDLSTNKFILADRQATTEEKE
QLKRELEAKNLELEKKNKALENKENQNIKLTDKVIELTAKNLINQ*
>PROKKA_00003 hypothetical protein
MFETCKKQYERKIERGILTTEYVEKQKVYIGIFLMNELLTQEQYQEVLEVLTVNIKVEDK
EVVSQ*
>PROKKA_00004 hypothetical protein
MENSFTIFIICKSKKIIRIKVVFLLLKINYMIKSKNLLNFLDIKEFVLRLLLEFILYKVK
IFYGRVQ*
>PROKKA_00005 hypothetical protein
MKNYYKRILIMFVMVLTIMSVGIMKNGTIANAATVGEQLLQPEDGWKRYDDNDSNITYST
KLSHDSESWFNSNSVEWCYNNTITDCVYGINTENEYCEFNFYGSKLRVISPYWWSSTPSV
DVYIDNKLIGNFSEKGSSDKYQVMVYEIDELNFSKHSVKIVNKDNSGAYFCIDAIDTDYN
GYLVNTNEENQSISLSQSSLNLKEGISEKLTATTTPSAVDINWSSSDEAVATVDSNGNVK
AIKEGQATITAKIKGTDIKSTCIVTVTKKDVPVEPEQPTNPEQEYIINTAYAKGDNTNNA
SGQVSIIFKGVAEAQLKVIKTADVDSVYVGDNFTYTIEITNTSDKIAKSVVIKDNAPNHI
QFIPSKVITTQGKVDSSSTYKNIVVNVGDIPPSGKVIIKIPVLVVE*
>PROKKA_00006 Bacterial Ig-like domain (group 2)
MNKKLKKIFVMFVMVLTIMGIGAIQNGVIANAATVGEQLTQPEDGWKRYKCGDEQITYIG
EGWHYGSTWAETLHSRYNYSGSKIKFNFTGDKLRLICGYWQTTSKDVDIIIDGKKIDKYV
INNGTNSNENILVYEKLDLNKKEHSLELVNNTDEYLTINAVDIDENEVLKLYNENISTIS
LDKSSLNLKENNTKKLTAITTPSAVDVEWLSSDEAIAKVDENGKVTGIKEGTCIVTVQIK
GTDVKATCEVTVTKEDIVNPEEPSIENGSLYIEMIDGNIKRADKSQIEKFKKWFISRDLD
ETESPIFKITNAKGNAEYLVHDKVVGFEIRE*
>PROKKA_00007 Bacteriocin UviB precursor
MDELIRVALGQGLGYGMFACLLVYVLKTTGERETKYQELLDKMADKFNVVEDIKEDVKEI
KSKIER*
>PROKKA_00008 hypothetical protein
MDRLLNKITSARWLIAVIMTIVFAVLAIKNTITTEFITIYTMVIAFYFSKDRKEIKE*
>PROKKA_00009 Lysozyme RrrD
MSNWKWCVQGENGKIIKGWYEDNGKWYYLNDEGIMQTSWIQDKDERWYYLKNDGSMATGW
LKSPYSGKWFYLNPVSNGYKGEMYRDGTYTIDGKEYKFNTSGAWIEDTLVSTICIDFIKS
WEGYFATPYIDCVGVKTLGYGMTGKEIEGLEYVTEGQATSMLKEWINEKYAPTIKKDLES
KNVNLKQHEFDALVSFTYNCGTSGLLGSTLYKNVCNGIRDKDTITSNFQAWSNGGGRRIE
GLYRRRTKEAAMFLSADYTGNV*
>PROKKA_00010 helix-turn-helix protein
MVKLSLEVILVAIKNKLLEIRLKNGYKYAKDFSDYLGINNQQYGRYESNKKQPNLEVLYK
ISKKLGIKIEDIIDFEKEQL*
>PROKKA_00011 (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB
MNFDIEKLEKIKVSDGQEFFFIQTFGCQMNEEDSEKLSGMLKSQGYEETENRDEASIVIF
NTCCVRENAENKVFGNLGRLKNQKEKNPNLIIALCGCMMQQKGMADEILSRFPYVDIIFG
THNAYKFPEYLHRVQVEGVQVKEIFDKETEIVEGVPIDRKSNVKAFVTIMYGCNNFCTYC
VVPYVRGRERSRRPEDIENEIKELVSNGYKEITLLGQNVNSYGKGLEEEITFAQLLRRIN
EIDGLERLRFMTSHPKDLTLDVVYAIRDCDKLCEQIHLPVQSGSNEILQKMNRHYNKEQY
LELAKKIREEIPDVTFSTDIIVGFPGETEEDFEETINLVKEVRYDAAFTFIYSRRNHTPA
DKMEDQIPDDVKHDRFNRLVAAVNEGIVVGNKAAEGKIYEVLVEGTSKNNENKLTGRTRN
AKLVNFDGCKEMIGKLVKVKIIEAKSFSLVGEVVEQ*
>PROKKA_00012 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MAKESKTNAMRILDSSKIEYTTYNYQNKDGKIDGVAVANKINKNENEVFKTLITQGHSKE
FYVYVVPVAQELDMKKAAKAAYEKSIEMIHIKDINKITGYIRGGCSPIGMKKTFKTFFHN
TALNCETIVFSGGKIGSQIEMNPRQLENILDCIFVDIIK*
>PROKKA_00013 Botulinum neurotoxin type E precursor
MPKINSFNYNDPVNDKTILYIKPGGCQQFYKSFNIMKNIWIIPERNVIGTIPQDFLPPTS
LKNGDSSYYDPNYLQSNEEKDRFLKIVTKIFNRINDNLSGGILLEELSKANPYLGNDNTP
NNQFHIGDASAVEIKFSNGSQSILLPTVIIMGAEPDLFETNSSNISLKNNYMPSNHGFGS
IAIVTFSPEYSFRFNDNSMNEFIQDPALTLMHELIHSLHGLYGAKGITTKYTITQQQNPL
ITNIRGTNIEEFLTFGGTDLNIITNAQSNDIYTNLLADYKKIASKLSQVQVSNPQLNPYK
DIFQEKYGLDKNASGIYSVNINKFDDIFKKLYSFTEFDLATKFQVKCRQTYIGQYKYFKL
SNLLNNSIYNISEGYNINTLKVNFRGQNTNLNPRIITQLTGRGLVKKIIRFCKNIVFSKG
ITKSICIEINNGELFFVASENSYNDDNINTPKEIDDTVTSNNNYENDLDQVILNFNSESA
PGLSDEKLNLTIQNDAYIPKYDSNGTSDIEQHDVNELNVFFYLDAQKVPEGENNVNLTSS
IDTALLEQPKIYTFFSSEFINNVNKPVQAALFVSWIQQVLVDFTTEANQKSTVDKIADIS
IVVPYIGLALNIGNEAQKGNFKDALELLGAGILLEFEPELLIPTILVFTIKSFLGSSDNK
NKVIKAINNALKERDEKWKEVYSFIVSNWMTKINTQFNKRKEQMYQALQNQVNALKTIIE
SKYNSYTLEEKNELTNKYNIEQIENELNQKVSIAMNNIEIFLTESSISYLMKLINEVKIN
KLREYDENVKTYLLDYIIKHGSILGESQQELNSMVIDTLNNSIPFKLSSYTDDKILISYF
NKFFKRIKSSSVLNMRYKNDKYVDTSGYDSNININGDVYKYPTNKNQFGIYNDKLSEVNI
SQNDYIIYDNKYKNFSISFWVRIPNYDNKIVNVNNEYTIINCMRDNNSGWKVSLNHNEII
WTLQDNAGINQKLAFNYGNANGISDYINKWIFVTITNDRLGDSKLYINGNLIDKKSILNL
GNIHVSDNILFKIVNCSYTRYIGMRYFNIFDKELDKTEIETLYNNEPNTNILKDFWGNYL
LYDKEYYLLNVLKPNNVIDSNRDSTFSIHNIRSTIVLANKLYLGIKVKIQRVNNSSTNDN
LVRKNDQVYINFVPIKTHLFPLYADTNTTNKEKTIKSSSSGNRFNQVVVMNSVGNNCTMN
FKNNNGNNIGMLGFKDNTLVASTWYYTHMRDNTNSNGCFWNFISEEHGWQEK*
>PROKKA_00014 Helix-turn-helix domain protein
MNRNIIGKKVRIIRKAKNLTQEELIVRIQLKGLNINRPMLSRIETDSREVYDFKVKAIAE
ALDISVDELFIQN*
>PROKKA_00015 Replication-associated recombination protein A
MTPLAERMRPTKLEDFVGQKQIIGEGKPLYNIIKSKNIVNCILYGPPGTGKTTLANIMAN
YVDRKFYKLNATTASVKDIQEIASSLDTLLGYNGVVVYIDELQHFSKKQQQSLLEFIEKG
QITLIASTTENPYFVLHKAILSRCNIFTFKPLTTDDIKFGVVKAIERAIENGMEIKYTDD
AISYIAEISQGDYRKAYNILELGIISSLKRTLEITVEYIEELEQSHIRFDASGDEFYNSL
SALQKSIRGSDADAAIHYLARLTKSGNLTAIVRRLGVIVAEDIGLAHPNALTVVNSGLEL
VLKVGLPEAQLILSELVIYLATLPKSNSAYLAIKSAMQDLENKNVGDVPVHLKDAHYSSA
QKLGVGGYKYPHDYSNNYVKQKYMPQELRDTIYYIPQENKYEGSIKNYWKNIKE*
>PROKKA_00016 hypothetical protein
MGKVGRKENCNISDNDMLVALERYTREFPNEKINIKKLADFSGIERHYWYSRKGFREKIE
EINSISYEKYDIISDGDRKKIKFPNVDEVVDNNFRNKKRLKFILNSFFLTYQDFYESSCE
AYKLKKDINILKDKIIKYEDEIQKLKNERDKFRELSNYNENKYYEIAIRSRERNFRKENN
IKSNVIEINNKNIKAYSTDEDDLDSLLNRIDD*
>PROKKA_00017 hypothetical protein
MNNKQQYKLALREGLLVNQIANNSDSLVIVTKELKIYKEEELDYYKEKFNYFKKKGRIVN
CVFNDLIWTLSETDEGGYKSNRNIKFSINFINKNNIIKAYLINLLINLININTIVERVRV
VSDIINISNFFDIDKFNEFEEYIESTFDNNKLNMKDYTMNFISFIRDNVDEEYCNYLVSL
PNEYFSKTREIPDYTSILKFDFLLDKYLKNSDEKEFFRYYPIVLWWKICSKIPLRPCEFM
ILKKDCVYEKNRKYYIRIRRCKPHGFVNKALNIRKEQSFRINKEIYDLVMKVVSHKSHDC
EFLLSKNLYNKYYTQYTYKEELVQGRVMRSYNLDKCLKDFYYYEINNKNIQTVISKKDVK
ESLSQQFYRDCMVSLQLGDARHLAIINLVLQGTNSYLIREMCGHRDINSHLHYIDHAKTY
ITSKVLVLTDIRKLEIKLANIYSNESFEYGNKRNNKVSNLLYNEYKKVGDIYCKRYVGRK
EMFPFLCLTDCDECNDKVETDFTGNTDEEIKTNKMEIERQFQIIEKYLKDAQFNSIIDSK
NERVLFESQKNIEESANKLNYLISKEAELEAKIFFGGMITKEE*
>PROKKA_00018 hypothetical protein
MNKENVVIELEDAAKEINPKCYKYFMKKLKTLNNINIFDKNGKLFITKNDFEKLKRNKAS
KIPYHIDIPNGYASRNEAVKKYNINYNSLRHNEEKGIIKTAISGGIAFLEKESIEKHIEF
LKYIEKINNDDNWIKVSSLRGKPYYDRISYTVRRNDFKNDLIKIGIGRTAEFFITRKLYK
EIINGKHKIIVTSQHKKKILKDDIEGIITKLLIETGVNSIRQKAKMKQLIKVKEISELSG
IDYEEIIESRRYFNGEIVKEQNIEYMHRYDIENIMKNFGYYSIKKLSKICGISFSTLIRD
FNIANFLGIYINFKIDKDFFVDINGVEIILKEFSKNYIATLTLDEIYRERMKLFPDEFFK
TYKLADEFIVKKKRNCYRPYGEDTTSYNRVINSIENLVNYLDKEIFEYSAEELLKLVSNT
NIVKRGYQAHVCQFINYVKRKMRNDCEYNKVFGLTLLTQYKIEKGENYLEKIYDKETWSK
YYILLKDIDKHIVNAIKDPRYAQSWLYCILNLSVTWRKKNIILSLPRIKLQEIGVYEFEW
FSSKNVFTYSMAELVLNQIKFSLDGVIAYKNRRHLHINIPMSLKISTAIAFIICEIHCRE
KSKDNIMYELAQSYIRKSDYKKLFEDDKLLNFENLKCTRSIISYGFSHAINTIGTVPAAY
KIYSNRRSHSDSEQKITNVTGDHYIALDGIENGAKEFMFHVVERGAFGFMYYKLFKCFFD
KKDFENISQEQLTDLTKYSDQILNPRTLENIADKFIENDRINKLSIFEILWYSSIIKNKG
KRDLSSKSNIFLAIMIDLYKKQSEDLLGKSDEFKTFVDEKYLQLDAEIEDILKNKISTSK
IIDNILNGSNCCYSKDTNCIFDRIERKELCPYKYEDNGGKSCVGCKYNLLTVYALNEINE
KMQTLLDKIQKKSYFTKEEIQKNSYILKNYVSIILEASVHFKNEEFLSNYINLKMIKTKI
YKLKSEGKIINI*
>PROKKA_00019 hypothetical protein
VFIISNVIELRNTNSKYRFKVKVCKYKREGRCEDHLFQKAIIVLFDNITGKSRVHEFTEF
AIREFGKNRIKTQVDYLGKLVKFLNYVIKNKDKKNFKYLDFYDVEEFSQEIALDVQMNTF
NIYKMVLSRFYRYLAQKEWLINVSINDFIIKESEKNGGVMIKYDIPICNIDIPNNIHRRN
THVMEYELQAMLLEVAIEEVNIIALAIFFQMFGGLRSGEIVNLTHSAVQCIGPYGRYGML
LDITDRNLRLDLKNNQAKGYSKKSRKQKVISPFNMLEKIYIQHMKKYKCVDDSGAIFVNK
DGMPMTIGSYNYYFDKLKKIFLKRLKESDNPTLKVQGDILCAAKWKTHIGRGIFSNNLGE
FMSASELKIARGDKYINSSDSYIEETKKIGKLYEENAEGAFQLLIKKINE*
>PROKKA_00020 Replication-associated recombination protein A
MSPLADLMRPSKIEDFVGQRHILGKNTPLYNLIKSKKICNCIFYGPPGTGKTTLANIMAK
YVDKKFYKLNATTASVKDIQNITSELDNLLNYAGVVLYIDELC*
>PROKKA_00021 molybdenum cofactor biosynthesis protein MoaC/MOSC-domain-containing protein
MGECIMPTNGVFAKVIEGGQMKIGDEIEIASGIEKMY*
